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Abstract
Site-directed mutants of yeast ATPase were previously studied after introduction of mutant alleles into a yeast strain where
these alleles were constitutively expressed while the expression of the wild-type chromosomal ATPase gene was turned off. As
a functional H pump is essential, strong selective pressure leads to the accumulation of revertants during growth of cells
harboring variants with low activity. Thus, constitutive expression of the mutant gene can select phenotypes which reflect
events such as gene conversion or reversion. We have therefore re-evaluated the phenotypes of non-dominant lethal alleles in
an alternative set of conditional expression systems. We show that eight of 11 previously described site-directed mutations
behave as recessive lethal alleles. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
The plasma membrane H-ATPase from Saccha-
romyces cerevisiae belongs to the large family of cat-
ion ATPases which form a transient aspartyl-phos-
phate intermediate [1]. The H-ATPase, encoded by
the PMA1 gene, generates an electrochemical proton
gradient essential for active nutrient uptake and in-
tracellular pH regulation [2^5].
Site-directed mutagenesis has been used to study
the role of potentially important residues of the en-
zyme. The mutant enzymes were tested for physio-
logical activity in a yeast strain where the expression
of the chromosomal wild-type ATPase was turned
o¡ and the mutant ATPases were constitutively ex-
pressed [6^9]. Several signi¢cant drawbacks of this
expression system have become apparent. (1) Since
the mutant gene is co-resident in the cell with a wild-
type gene, a dominant lethal mutation can be lost
during sequence shu¥ing by either gene conversion
with PMA1 or gene reversion [10^12]. (2) Because a
functional ATPase is essential, there is strong selec-
tive pressure for revertants to accumulate during
growth of cells harboring variants with low activity.
(3) When cells are transferred to glucose medium in
order to turn o¡ the wild-type chromosomal ATPase,
cells expressing inactive mutant ATPases stop grow-
ing. This can leave a signi¢cant background wild-
type enzyme in the plasma membrane. It was there-
fore important, ¢rst, to determine whether any of the
site-directed mutants studied was in fact dominant
lethal and, second, to characterize the non-dominant
lethal mutations using an alternative expression sys-
tem. Dominant lethal mutations were reported in a
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previous study [13]. Here, we have re-evaluated the
phenotype of non-dominant lethal mutant ATPases
using an expression system in which the mutant en-
zymes are conditionally expressed and accumulated
in secretory vesicles where they are analyzed [14].
2. Materials and methods
2.1. Yeast strains and growth media
S. cerevisiae strain SY4 is GAL MATa ura3 leu2
his4 sec6 pma1 : :YIpGAL-PMA1 and was used for
expression of the ATPase in secretory vesicles [14].
Strain XZ611 is Gal MATa ura3 leu2 trp1 [12] and
was used in immuno£uorescence experiments. Syn-
thetic media with 2% dextrose (SD), 2% lactic acid
(SL) or 2% galactose (SG) and the appropriate re-
quirements were used [15]. Yeast cells were trans-
formed using the lithium acetate procedure [16].
2.2. Expression of the ATPase in secretory vesicles
The construction of the pma1 alleles used in this
study has been described [6^9] and all of them were
re-sequenced to ensure that only the desired muta-
tion was present. Site-directed mutations were intro-
duced into plasmid pPMA1.2 [14] by exchange of
either a 1.5 kb EcoRV-BamHI (E129QCK474Q) or
a 2.2 kb XbaI (D560NCT912A) fragment with the
corresponding fragment in plasmid pPMA1.2. After
the fragments were moved into plasmid pPMA1.2, a
3.77 kb SacI-HindIII fragment containing the entire
ATPase coding sequence was cloned into vector
YCp2HSE [14] placing the mutant alleles under the
control of a heat-shock inducible promoter. The re-
sulting plasmids were transformed into strain SY4
[14]. This strain has the chromosomal PMA1 gene
under the control of the GAL1 promoter and also
carries the sec6-4 mutation that blocks fusion of se-
cretory vesicles with the plasma membrane. For ex-
pression studies, SY4 transformants were grown to
mid-exponential phase (OD660V0.5) on SG and
shifted to SD for 3 h to turn o¡ transcription of
chromosomal PMA1, then shifted to 37‡C for 2 h
to turn on expression of the plasmid-borne gene
and block fusion of secretory vesicles with plasma
membrane. Secretory vesicles were then isolated by
di¡erential centrifugation as described [14]. Each
plasmid was rescued from yeast expressing functional
Pma1p and the corresponding pma1 allele sequenced
to ensure that only the desired mutation was present.
2.3. Construction of HA-tagged pma1 alleles
The HA-tagged pma1 alleles used in this study
were generated by exchange of either a 0.6 kb
EcoRV-BstEII (T231G and S234A) or a 3.4 kb
BstEII-HindIII (K474H, K474H, D560N, D634N
and D730N) fragment containing the desired muta-
tion with the corresponding fragment in plasmid
pFP302. The plasmid pFP302 is a derivative of the
URA3 single copy plasmid YCp50 [17] and it carries
a HA-tagged wild-type PMA1 under the control of
the GAL1 promoter [13].
2.4. Biochemical methods
Quantitative immunodetection of the ATPase was
performed as described [14], using a⁄nity puri¢ed
rabbit polyclonal antibody against yeast ATPase
[18]. ATPase activity was assayed at pH 6.5 with
5 mM ATP [19]. H pumping into secretory vesicles
was monitored by £uorescence quenching of acridine
orange [14]. Protein concentration was determined by
the Bradford method [20] with the Bio-Rad Protein
Assay Reagent and bovine IgG as standard. Local-
ization of HA-tagged Pma1 was determined by im-
muno£uorescence as described [13].
3. Results
The site-directed mutations characterized in this
study and their topological location in Pma1p are
illustrated in Fig. 1. The mutant genes were placed
under the control of a heat-shock inducible promoter
in the plasmid YCp2HSE [14]. Plasmid YCp2HSE
containing the mutant genes were transformed into
strain SY4 [14]. This strain has the chromosomal
PMA1 gene under the control of the GAL1 gene
promoter and also carries the temperature-sensitive
sec6-4 mutation that blocks fusion of secretory
vesicles with plasma membrane. Thus, when cells
were incubated in galactose medium at 23‡C the
chromosomal wild-type ATPase was produced and
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when cells were transferred to glucose medium at
37‡C the expression of the wild-type ATPase was
repressed and the mutant ATPase was expressed. Be-
cause strain SY4 carries a temperature-sensitive sec6-
4 mutation the shift to 37‡C also led to the accumu-
lation of the newly synthesized mutant ATPase in
secretory vesicles. Secretory vesicles were puri¢ed
by di¡erential centrifugation for analysis of the mu-
tant ATPase [14]. Table 1 summarizes the behavior
of the mutant enzymes. In most of the cases (T231G,
S234A, K474H, K474Q, D560N, D634N, and D730N
mutations) quantitative immunoblotting revealed
Fig. 1. Location of H-ATPase mutations characterized in this study. Phosphorylation site (Asp-378) and positions of the mutations
are indicated within the proposed structural topography of the H-ATPase as determined from hydropathy analysis.
Table 1
Analysis of mutant ATPase accumulated in secretory vesicles
Allele expressed Amount of
ATPasea
ATPase activityb H transportc
Uncorrected (Wmol/min/mg) Corrected (%) Uncorrected (% Q/mg) Corrected (%)
Wild-type 100 0.42 100 360 100
Noned 7 0.04 n.d.
E129Q 100 0.35 83 278 77
D226N 80 0.04 n.d.
T231G 5 0.04 n.d.
S234A 18 0.05 n.d.
K474H 8 0.04 n.d.
K474Q 7 0.05 n.d.
D560N 10 0.06 n.d.
D634N 9 0.05 n.d.
D730N 8 0.05 n.d.
S911A 100 0.50 120 400 110
T912A 85 0.10 30 149 40
n.d., not determined.
aQuanti¢ed by immunoassay. The value for the wild type was considered 100%.
bATPase activity was assayed at pH 6.5 with 5 mM ATP. The speci¢c activity of each secretory vesicle preparation was measured as
the di¡erence between hydrolysis in the absence and in the presence of 250 WM orthovanadate. Values are the average of two inde-
pendent experiments di¡ering less than 15%. Each mutant value was corrected for the relative amount of mutant protein in the secre-
tory vesicle preparation.
cFluorescence quenching of acridine orange was used to monitor pumping of protons into secretory vesicles. Similar values (within
15%) were obtained with two di¡erent secretory vesicle preparations independently isolated. Each mutant value was corrected for the
relative amount of mutant protein in the secretory vesicle preparation.
dSecretory vesicles were isolated from SY4 transformed with the vector YCp2HSE carrying no PMA1 gene.
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that mutations led to a substantial decrease in the
amount of Pma1p in the secretory vesicles. The
amounts of Pma1p antigen detected in these mutants
were background or barely above the background
(S234A) given with the YCp2HSE vector alone. Pos-
sible explanations for the failing of mutant enzymes
to reach the vesicle would be that these mutations
render enzymes abnormally susceptible to degrada-
tion or, alternatively, that mutations prevent proper
folding or insertion of Pma1p into the membrane
and led to retention of Pma1p at an early stage of
biogenesis. To test whether these mutations alter the
biogenesis of Pma1p, we studied the transport of
mutant ATPases to the cell surface. To this end,
we introduced the HA epitope in the mutant proteins
and HA-tagged proteins were expressed under the
control of the GAL1 promoter in a wild-type strain.
We examined the location of these HA-tagged mu-
tant proteins by immuno£uorescence decoration
after galactose induction. The results are presented
in Fig. 2. In all the cases the HA antibody decorated
a set of cytoplasmic structures suggesting that muta-
tions led to retention of Pma1p in an early step of
the secretory pathway. All of the remaining mutant
ATPases (E129Q, D226N, S911A and T912A)
reached the secretory vesicles at levels ranging from
80% (D226N) to 100% (S911A). In these cases, secre-
tory vesicle preparations were next assayed for their
ability to hydrolyze ATP and to analyze ATP-de-
pendent H transport. In one case (D226N), muta-
tion led to an activity value not signi¢cantly above
background, suggesting that Asp-226 plays an im-
portant role in ATPase function. In the remaining
mutants (E129Q, S911A and T912A) activity values
ranged from 30% hydrolysis/40% transport in T912A
to 120% hydrolysis/110% transport in S911A. In
these cases, kinetic analysis (data not shown) gave
essentially wild-type values, e.g. Km for ATP and
Ki for orthovanadate.
4. Discussion
A speci¢c role for several amino acids in ATPase
function was assigned using site-directed mutagenesis
in combination with a constitutive expression system
of the mutant ATPases [6^9]. However, gene conver-
sion or reversion allowed the modi¢cation of domi-
nant negative phenotypes or inactive proteins. Dom-
inant lethal mutations were previously characterized
[13]. Here, we have analyzed the phenotype of non-
dominant lethal mutations by expressing the mutant
Fig. 2. Accumulation of the HA-tagged mutant protein in cyto-
plasmic structures. The transformant carried either the HA-
tagged PMA1 or HA-tagged pma1 genes under the control of
the GAL1 promoter. After galactose induction, cells were
stained for the nucleus (DAPI) or immunodecorated for the
HA-tagged Pma1p using a rhodamine-conjugated anti-HA anti-
body (anti-HA).
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ATPases in secretory vesicles where they are ana-
lyzed.
The present study shows that the previously pro-
posed role of Asp-226, Thr-231, Ser-234, Lys-474,
Asp-560, Asp-634, and Asp-730 in ATPase function
must be reconsidered. Amino acids Asp-226, Thr-231
and Ser-234 were proposed to be involved in energy
transduction as D226N, T231G and S234A mutations
caused uncoupling between ATP hydrolysis and H
transport [6,7]. The Lys-474 residue was suggested to
be essential for enzyme function as mutations at this
amino acid greatly decreased ATPase activity [6,7].
Amino acid Asp-560 was considered as part of the
ATP binding site as D560N mutation altered the nu-
cleotide binding speci¢city of the enzyme [6]. The
Asp-634 residue was proposed to form part of a
phosphatase domain, as the D634N mutation
blocked hydrolysis of the phosphorylated intermedi-
ate [7]. Finally, amino acid Asp-730 was described as
non-essential as D730N mutation had no noticeable
e¡ect on ATPase activity [7]. The fact that D226N
mutation greatly decreases ATPase activity and that
T231G, S234A, K474H, K474Q, D560N, D634N, and
D730N mutations led to retention of Pma1p early in
the secretory pathway suggest that these amino acids
must be important for protein folding and/or target-
ing although a speci¢c role cannot be assigned. The
observed behavior of these mutations is consistent
with a recessive lethal phenotype.
In the case of the Glu-129 and Ser-911 residues,
the results obtained in the present study are essen-
tially coincident with those previously shown [7,9]
and suggest that amino acids Glu-129 and Ser-911
are non-essential for ATPase function.
Amino acid Thr-912 was considered to form part
of a regulatory domain as T912A mutation disturbs
the glucose-triggered Vmax increase of the enzyme [9].
The results shown here are consistent with the pro-
posed role for Thr-912. The T912A mutation led to a
substantial decrease in activity without altering the
Km of the enzyme for ATP, thus suggesting that the
decreased activity could be due to a defect in Vmax.
Further work which combines new site-directed
mutations with the analysis of revertants, expression
of the mutant ATPases in secretory vesicles and the
transit of mutant ATPases to the cell surface will
allow the assignment of speci¢c roles for the essential
residues described in this study.
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